Target intelligence / Profile preview

RAMOSA1 ENHANCER LOCUS 2 LIKE 2 (RELK2) (RELK2)

Target
RELK2
Molecular classification
Transcriptional corepressor, TOPLESS (TPL) family, Groucho/Tup1 family
01

Overview

RAMOSA1 ENHANCER LOCUS 2 LIKE 2 (RELK2) is a transcriptional corepressor in maize (Zea mays) belonging to the highly conserved TOPLESS (TPL) family (Liu et al., 2019). It plays a critical role in plant development by regulating meristem maintenance and size through the repression of specific target genes, often in conjunction with other REL family members (Gregory et al., 2024). RELK2 is a key target of the biotrophic fungal pathogen Ustilago maydis, which secretes effector proteins such as Tip6 to recruit RELK2 and reprogram host transcription, leading to the formation of plant tumors known as smut (Huang et al., 2024). While not a human therapeutic target, RELK2 is of significant interest in agricultural biotechnology for its potential to be modulated to increase crop yield and enhance disease resistance. The protein functions as a molecular bridge, recruiting histone modifiers and other repressive machinery to silence gene expression in response to developmental and environmental cues (Liu et al., 2019). Loss of RELK2 and its paralogs leads to severe defects in vegetative and reproductive development, including the failure to maintain the shoot apical meristem (Gregory et al., 2024).

Other names
RAMOSA1 ENHANCER LOCUS 2-LIKE 2Topless-related 2TPL2Zm00001eb041440
02

Mechanism of action

No known pharmacological drugs; targeted by fungal effectors (e.g., Tip6, Tip7) to recruit the corepressor to host promoters and silence defense-related or growth-regulating genes.

03

Biological functions

Transcriptional repressionMeristem maintenancePlant developmentHormone signalingRedox balance
04

Disease associations

Plant tumorigenesisSmut disease
05

Safety considerations

Developmental defects in plantsReduced seed yield

Beyond the preview

Go deeper on RAMOSA1 ENHANCER LOCUS 2 LIKE 2 (RELK2) (RELK2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAMOSA1 ENHANCER LOCUS 2 LIKE 2 (RELK2) (RELK2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call